Back to News
Market Impact: 0.25

Multiconsult fourth quarter and full year 2025 – Stable quarter in a challenging market

Corporate EarningsCapital Returns (Dividends / Buybacks)Company FundamentalsLegal & LitigationM&A & RestructuringInfrastructure & DefenseCorporate Guidance & OutlookTransportation & Logistics

Multiconsult reported stable top-line growth with Q4 net operating revenues rising 5.4% to NOK 1,521.5m and FY revenues up 5.1% to NOK 5,657.3m, with organic growth ~4% when adjusted for calendar effects. Profitability weakened: FY EBITA fell to NOK 394.8m (EBITA adj. NOK 431.7m) with an adjusted margin of 7.6% (down from 9.2%), and net profit/EPS declined to NOK 252.6m / NOK 9.22; Q4 EBITA was impacted by NOK 18.0m of Sotra-related legal expenses/write-downs (NOK 36.9m for the year). Order intake was NOK 1,636m in Q4 (FY 6,077m) with a backlog of NOK 4,233m, FTEs rose ~4.6% and the board proposes an ordinary dividend of NOK 5.00/share; management is implementing cost and margin measures amid a highly competitive market.

Analysis

Market structure: Multiconsult (MULTI) is operating in a structurally competitive Nordic engineering market where price pressure and rising input costs compress margins (adjusted EBITA margin fell to 7.6% from 9.2%). Winners are niche specialist firms with defense or transport footholds and strong backlog visibility; losers are mid‑tier consultancies with rising headcount (+4.6% FTE) and falling billing ratios (71.8%), which erode margin leverage. Expect modest market share shifts toward firms that can cross‑sell defence/transport frameworks (benefits to KONGSBERG/KOG.OL suppliers) and away from undifferentiated generalist consultancies. Risk assessment: Key tail risks include a larger-than‑announced write‑down or adverse legal ruling on the Sotra project (>NOK 50m), rapid backlog erosion (>10% y/y), or a macro slowdown that reduces public capex; any would materially compress cash flows and widen credit spreads. Near term (days–weeks) risks center on sentiment around the Sotra legal update and integration of ViaNova; medium term (3–12 months) on order intake trends and margin-restoration execution; long term (>12 months) on ability to reach 10% EBITA. Hidden dependency: rising FTE without billing ratio recovery indicates margin recovery depends more on pricing/new frameworks than cost cutting. Trade implications: Direct play — initiate a tactical 2–3% long position in MULTI on any pullback >8% from current price, targeting 20–30% upside in 6–12 months if margins recover to ~9–10% and backlog stabilizes; use a stop loss if backlog falls below NOK 4.0bn or adjusted EBITA margin slips under 6%. Pair trade — long MULTI vs short AFRY.ST (or SWECO‑B.ST) 1:1 to isolate sector execution risk, because MULTI has new defense frameworks and niche transport strength via ViaNova. Options — buy 3–6 month protection (buy puts one strike below current) sized 0.5–1% notional to hedge Sotra/legal outcomes; alternatively use a 9–12 month call spread (buy ATM, sell +20% strike) to play margin re‑rating cost‑effectively. Contrarian angle: Consensus focuses on margin squeeze; market may underweight Multiconsult’s structural gains in transport/defence — ViaNova adds 129 specialists and two defence frameworks which could lift higher‑margin backlog by >NOK 500m over 12–18 months if converted. Reaction could be overdone if the market prices in prolonged margin degradation; monitor three concrete catalysts (next quarterly order intake, legal ruling on Sotra within 90 days, and integration KPIs for ViaNova at 6 months) — positive reads could trigger rapid rerating given current subdued sentiment.